Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
237.00
+1.09 (0.46%)
At close: Jun 5, 2026, 4:00 PM EDT
240.25
+3.25 (1.37%)
After-hours: Jun 5, 2026, 6:49 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $266 | Buy | Maintains | $266 | +12.24% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $262 | Buy | Reiterates | $262 | +10.55% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $289 | Buy | Reiterates | $289 | +21.94% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $230 → $255 | Buy | Reiterates | $230 → $255 | +7.59% | Apr 27, 2026 |
| Citi | Citi | Buy Reiterates $276 → $282 | Buy | Reiterates | $276 → $282 | +18.99% | Apr 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | +16.88% | Feb 27, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $220 | Buy | Maintains | $220 | -7.17% | Dec 10, 2025 |